Genetic characterization of incident HIV type 1 subtype E and B strains from a prospective cohort of injecting drug users in Bangkok, Thailand

AIDS Res Hum Retroviruses. 2000 May 20;16(8):699-707. doi: 10.1089/088922200308693.

Abstract

We obtained specimens from 128 HIV-1 seroconverters identified from 1995 through 1998 in a prospective cohort study of 1,209 HIV-negative injecting drug users (IDUs) in Bangkok, Thailand. Epidemiologic data indicated that parenteral transmission accounted for nearly all infections. HIV-1 DNA from the C2-V4 env region was sequenced, and phylogenetic analyses determined that 102 (79.7%) of the specimens were subtype E and 26 (20.3%) subtype B strains. All subtype B strains clustered with strains often referred to in previous studies as Thai B or B'. The interstrain nucleotide distance (C2-V4) within subtype E strains was low (mean, 6.8%), and pairwise comparisons with a prototype subtype E strain, CM244, showed limited divergence (mean, 5.6%). The subtype B stains showed greater interstrain divergence (mean, 9.2%) and were significantly divergent from the prototype B strain HIV-MN (mean, 13.0%; p < 0.0001). The subtype E strains had significantly lower mean V3 loop charge than did subtype B strains (p = 0.017) and, on the basis of analysis of amino acid sequences, were predicted to be predominantly (91%) non-syncytium-inducing (NSI), chemokine coreceptor CCR5-using (CCR5+) viruses. The subtype B strains had a higher mean V3 loop charge, and a smaller proportion (23%) were predicted to be NSI/CCR5+ viruses. This study demonstrates that most incident HIV1 infections among Bangkok IDUs are due to subtype E viruses, with a narrow spectrum of genetic diversity. The characterization of incident HIV-1 strains from 1995 to 1998 will provide important baseline information for comparison with any breakthrough infections that occur among IDUs in Bangkok who are participating in an HIV-1 vaccine efficacy trial initiated in 1999.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Cohort Studies
  • Glycosylation
  • HIV Envelope Protein gp120 / chemistry
  • HIV Envelope Protein gp120 / genetics
  • HIV Infections / complications
  • HIV Infections / epidemiology*
  • HIV Infections / virology*
  • HIV-1 / classification*
  • HIV-1 / genetics*
  • Humans
  • Incidence
  • Molecular Sequence Data
  • Peptide Fragments / chemistry
  • Peptide Fragments / genetics
  • Phylogeny
  • Prospective Studies
  • Receptors, HIV / metabolism
  • Sequence Analysis, DNA
  • Substance Abuse, Intravenous / complications*
  • Thailand / epidemiology

Substances

  • HIV Envelope Protein gp120
  • HIV envelope protein gp120 (305-321)
  • Peptide Fragments
  • Receptors, HIV

Associated data

  • GENBANK/AF081710
  • GENBANK/AF081711
  • GENBANK/AF081712
  • GENBANK/AF081713
  • GENBANK/AF081714
  • GENBANK/AF081715
  • GENBANK/AF081716
  • GENBANK/AF081717
  • GENBANK/AF081718
  • GENBANK/AF081719
  • GENBANK/AF081720
  • GENBANK/AF081721
  • GENBANK/AF081722
  • GENBANK/AF081723
  • GENBANK/AF081724
  • GENBANK/AF081725
  • GENBANK/AF081726
  • GENBANK/AF081727
  • GENBANK/AF081728
  • GENBANK/AF081729
  • GENBANK/AF081730
  • GENBANK/AF081731
  • GENBANK/AF081732
  • GENBANK/AF081733
  • GENBANK/AF081734
  • GENBANK/AF081735
  • GENBANK/AF081736
  • GENBANK/AF081737
  • GENBANK/AF081738
  • GENBANK/AF081739